• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非首尔居民到首尔医疗机构就医治疗前列腺癌的医疗旅游。

Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul.

机构信息

Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

Department of Public Health and Preventive Medicine, Chungbuk National University Hospital, Cheongju, Korea.

出版信息

Cancer Res Treat. 2019 Jan;51(1):53-64. doi: 10.4143/crt.2017.468. Epub 2018 Feb 20.

DOI:10.4143/crt.2017.468
PMID:29458236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333968/
Abstract

PURPOSE

This study aims to investigate the trend in medical travel by non-Seoul residents to Seoul for treatment of prostate cancer and also to investigate the possible factors affecting the trend.

MATERIALS AND METHODS

This study represents a retrospective cohort study using data from theKoreanNationalHealth Insurance System from 2002 to 2015. Annual trends were produced for proportions of patients who traveled according to the age group, economic status and types of treatment. Multiple logistic analysiswas used to determine factors affecting surgeries at medical facilities in Seoul among the non-Seoul residents.

RESULTS

A total of 68,543 patients were defined as newly diagnosed prostate cancer cohorts from 2005 to 2014. The proportion of patients who traveled to Seoul for treatment, estimated from cases with prostate cancer-related claims, decreased slightly over 9 years (28.0 at 2005 and 27.0 at 2014, p=0.02). The average proportion of medical travelers seeking radical prostatectomy increased slightly but the increase was not statistically significant (43.1 at 2005 and 45.4 at 2014, p=0.26). Income level and performance ofrobot-assisted radical prostatectomy were significant positive factors for medical travel to medical facilities in Seoul. Combined comorbidity diseases and year undergoing surgery were significant negative factors for medical travel to medical facilities in Seoul.

CONCLUSION

The general trend of patients travelling from outside Seoul for prostate cancer treatment decreased from 2005 to 2014. However, a large proportion of traveling remained irrespective of direct distance from Seoul.

摘要

目的

本研究旨在调查非首尔居民前往首尔治疗前列腺癌的医疗旅游趋势,并探讨可能影响这一趋势的因素。

材料和方法

本研究使用了韩国国家健康保险系统 2002 年至 2015 年的数据,代表了一项回顾性队列研究。根据年龄组、经济状况和治疗类型,制作了患者出行比例的年度趋势图。多因素逻辑回归分析用于确定非首尔居民在首尔医疗机构接受手术的影响因素。

结果

2005 年至 2014 年期间,共有 68543 名患者被定义为新诊断的前列腺癌患者。从前列腺癌相关索赔案例中估计,前往首尔接受治疗的患者比例在 9 年内略有下降(2005 年为 28.0%,2014 年为 27.0%,p=0.02)。寻求根治性前列腺切除术的医疗旅行者的平均比例略有增加,但增加不具有统计学意义(2005 年为 43.1%,2014 年为 45.4%,p=0.26)。收入水平和机器人辅助根治性前列腺切除术的实施是前往首尔医疗机构进行医疗旅行的显著正因素。合并共病和手术年份是前往首尔医疗机构进行医疗旅行的显著负因素。

结论

2005 年至 2014 年期间,非首尔居民前往首尔治疗前列腺癌的总体趋势呈下降趋势。然而,无论距离首尔的远近,仍有很大一部分人选择出行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5492/6333968/03035503cc30/crt-2017-468f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5492/6333968/edc86b06f89d/crt-2017-468f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5492/6333968/03035503cc30/crt-2017-468f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5492/6333968/edc86b06f89d/crt-2017-468f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5492/6333968/03035503cc30/crt-2017-468f2.jpg

相似文献

1
Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul.非首尔居民到首尔医疗机构就医治疗前列腺癌的医疗旅游。
Cancer Res Treat. 2019 Jan;51(1):53-64. doi: 10.4143/crt.2017.468. Epub 2018 Feb 20.
2
Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.美国前列腺癌患者就诊距离对总死亡率的影响。
Cancer. 2017 Sep 1;123(17):3241-3252. doi: 10.1002/cncr.30744. Epub 2017 May 4.
3
Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study.韩国男性前列腺癌10年主要治疗模式的变化:一项基于全国人口的研究
Cancer Res Treat. 2016 Jul;48(3):899-906. doi: 10.4143/crt.2015.212. Epub 2015 Oct 20.
4
Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.日本初诊前列腺癌初始治疗的最新趋势。
Jpn J Clin Oncol. 2014 Oct;44(10):969-81. doi: 10.1093/jjco/hyu104. Epub 2014 Aug 6.
5
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.去势根治性前列腺切除术治疗伴骨转移的前列腺癌男性患者。
Eur Urol Oncol. 2018 May;1(1):46-53. doi: 10.1016/j.euo.2018.03.002. Epub 2018 May 15.
6
Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.肥胖与雄激素剥夺治疗后行根治性前列腺切除术的男性的去势抵抗性疾病和转移相关:来自 SEARCH 数据库的结果。
BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.
7
Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.手术技术在根治性前列腺切除术中对盆腔淋巴结清扫操作的应用及影响:来自共享平等准入区域癌症医院数据库的结果
Int J Urol. 2016 Mar;23(3):241-6. doi: 10.1111/iju.13027. Epub 2015 Dec 14.
8
Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.与澳大利亚昆士兰州被诊断患有前列腺癌的男性所接受治疗相关的因素。
BJU Int. 2012 Dec;110(11 Pt B):E712-9. doi: 10.1111/j.1464-410X.2012.011533.x. Epub 2012 Sep 27.
9
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.死亡率与雄激素剥夺疗法作为临床局限性前列腺癌初始治疗后生化复发的挽救性治疗手段
J Urol. 2017 Jun;197(6):1448-1454. doi: 10.1016/j.juro.2016.12.086. Epub 2016 Dec 19.
10
Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.前列腺癌初次根治性前列腺切除术或放疗后去势抵抗的差异风险
Anticancer Res. 2017 Oct;37(10):5631-5637. doi: 10.21873/anticanres.11998.

引用本文的文献

1
Inter-regional patient outmigration to Seoul in South Korea: the role of regional healthcare quality perceptions.韩国患者向首尔的跨地区外流:地区医疗质量认知的作用。
BMC Health Serv Res. 2025 Mar 19;25(1):407. doi: 10.1186/s12913-025-12464-8.
2
Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study.分析过去 5 年中前列腺癌诊断后前列腺切除术中国家和地区枢纽作用的趋势:一项全国范围内基于人群的研究。
Investig Clin Urol. 2024 Mar;65(2):124-131. doi: 10.4111/icu.20230333.
3
Regional disparities in the availability of cancer clinical trials in Korea.

本文引用的文献

1
Does uneven geographic distribution of urologists effect bladder and prostate cancers mortality? National health insurance data in Korea from 2007-2011.泌尿科医生的地理分布不均会影响膀胱癌和前列腺癌的死亡率吗?来自韩国2007 - 2011年的国民健康保险数据。
Oncotarget. 2017 May 20;8(39):65292-65301. doi: 10.18632/oncotarget.18036. eCollection 2017 Sep 12.
2
Inequalities in non-communicable diseases between the major population groups in Israel: achievements and challenges.以色列主要人群间非传染性疾病的不平等:成就与挑战。
Lancet. 2017 Jun 24;389(10088):2531-2541. doi: 10.1016/S0140-6736(17)30574-3. Epub 2017 May 8.
3
韩国癌症临床试验可及性的地区差异。
Epidemiol Health. 2024;46:e2024006. doi: 10.4178/epih.e2024006. Epub 2023 Dec 11.
4
Cancer care patterns in South Korea: Types of hospital where patients receive care and outcomes using national health insurance claims data.韩国的癌症护理模式:利用国家健康保险索赔数据了解患者接受护理的医院类型和结果。
Cancer Med. 2023 Jul;12(13):14707-14717. doi: 10.1002/cam4.6093. Epub 2023 May 18.
5
Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study.从韩国非首尔地区前往首尔进行原发性乳腺癌治疗的国内医疗旅行:一项全国性队列研究。
Ann Surg Treat Res. 2023 Feb;104(2):71-79. doi: 10.4174/astr.2023.104.2.71. Epub 2023 Jan 31.
6
Do Patients Residing in Provincial Areas Transport and Spend More on Cancer Treatment in Korea?患者在韩国治疗癌症的交通和花费更高吗?
Int J Environ Res Public Health. 2021 Sep 1;18(17):9247. doi: 10.3390/ijerph18179247.
7
Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis.韩国 2003 至 2013 年前列腺癌发病率的时间趋势:一项年龄-时期-队列分析。
Cancer Res Treat. 2020 Jan;52(1):301-308. doi: 10.4143/crt.2019.194. Epub 2019 Aug 1.
8
Why is Life Expectancy in Busan Shorter than in Seoul? Age and Cause-Specific Contributions to the Difference in Life Expectancy between Two Cities.为什么釜山的预期寿命比首尔短?两个城市预期寿命差异的年龄和病因特异性贡献。
Yonsei Med J. 2019 Jul;60(7):687-693. doi: 10.3349/ymj.2019.60.7.687.
9
Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015.2005年至2015年韩国前列腺癌患病率和根治性前列腺切除术率随年龄的变化趋势及结构变化
Yonsei Med J. 2019 Mar;60(3):257-266. doi: 10.3349/ymj.2019.60.3.257.
Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
美国前列腺癌患者就诊距离对总死亡率的影响。
Cancer. 2017 Sep 1;123(17):3241-3252. doi: 10.1002/cncr.30744. Epub 2017 May 4.
4
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care.重新定义和情境化机器人辅助根治性前列腺切除术的医院量效关系:对集中化治疗的影响。
J Urol. 2017 Jul;198(1):92-99. doi: 10.1016/j.juro.2017.01.067. Epub 2017 Jan 30.
5
High volume is the key for improving in-hospital outcomes after radical prostatectomy: a total population analysis in Germany from 2006 to 2013.高手术量是改善根治性前列腺切除术后院内结局的关键:2006 年至 2013 年德国的全人群分析。
World J Urol. 2017 Jul;35(7):1045-1053. doi: 10.1007/s00345-016-1982-4. Epub 2016 Dec 8.
6
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
7
Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013.机器人推动德国根治性前列腺切除术市场:2006 年至 2013 年的全人群分析。
Prostate Cancer Prostatic Dis. 2016 Dec;19(4):412-416. doi: 10.1038/pcan.2016.34. Epub 2016 Aug 23.
8
Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?旅行距离与前列腺癌治疗选择之间的关联:地理位置是否会减少患者的选择?
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):313-317. doi: 10.1016/j.ijrobp.2016.05.022. Epub 2016 May 27.
9
Equity in Cancer Care and Outcomes of Treatment: A Different Type of Cancer Moonshot.癌症护理中的公平性与治疗结果:一种不同类型的癌症登月计划。
JAMA. 2016;315(12):1231-2. doi: 10.1001/jama.2016.2242.
10
Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.直肠癌的癌症护理地理可及性与放射治疗接受情况之间的关联
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):719-28. doi: 10.1016/j.ijrobp.2015.12.012. Epub 2015 Dec 17.